Surgalign Holdings (Surgalign Holdings) Additional Paid-In Capital : $610.42 Mil(As of Mar. 2023)

View and export this data going back to 2000. Start your Free Trial

What is Surgalign Holdings Additional Paid-In Capital?

Surgalign Holdings's quarterly additional paid-in capital increased from Sep. 2022 ($605.46 Mil) to Dec. 2022 ($607.25 Mil) and increased from Dec. 2022 ($607.25 Mil) to Mar. 2023 ($610.42 Mil).

Surgalign Holdings's annual additional paid-in capital increased from Dec. 2020 ($517.12 Mil) to Dec. 2021 ($585.52 Mil) and increased from Dec. 2021 ($585.52 Mil) to Dec. 2022 ($607.25 Mil).

Surgalign Holdings Additional Paid-In Capital Historical Data

The historical data trend for Surgalign Holdings's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Surgalign Holdings Additional Paid-In Capital Chart

Surgalign Holdings Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Additional Paid-In Capital

Get a 7-Day Free Trial

433.14

498.44

517.12

585.52

607.25

Surgalign Holdings Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
Additional Paid-In Capital	Get a 7-Day Free Trial															602.85	604.25	605.46	607.25	610.42

Surgalign Holdings Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Surgalign Holdings Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Surgalign Holdings's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Surgalign Holdings (Surgalign Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Surgalign Holdings Inc (OTCPK:SRGAQ) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

520 Lake Cook Road, Suite 315, Deerfield, IL, USA, 60015

Website

https://www.surgalign.com

Surgalign Holdings Inc is a global medical technology company advancing the science of spine care, focused on delivering innovative solutions that drive superior clinical and economic outcomes. The company continues to invest in clinically validated innovation to deliver the Best surgical outcomes and improve patient's lives. It markets products throughout the United States and in more than 50 countries worldwide through an expanding network of top independent distributors. The U.S. market accounts for the vast majority of revenue. It has commercial and design centers in San Diego, California, and Wurmlingen, Germany.

Executives

Elizabeth A. Lapuma	director	520 LAKE COOK ROAD, SUITE 315, DEERFIELD IL 60015
Jill Kathleen Frizzley	director	P.O. BOX 1541, ONE BLUE HILL PLAZA, PEARL RIVER NY 10965
Paolo Amoruso	officer: Chief Legal Officer	C/O HYPERDYNAMICS CORPORATION, 12012 WICKCHESTER LANE, SUITE 475, HOUSTON TX 77079
David Lyle	officer: Chief Financial Officer	6290 SEQUENCE DRIVE, SAN DIEGO CA 92121
Marc E. Mackey	officer: EVP, Digital Surgery	520 LAKE COOK ROAD, SUITE 315, DEERFIELD IL 60015
Terry M. Rich	officer: President, Global Spine	520 LAKE COOK ROAD, SUITE 315, DEERFIELD IL 60015
William Scott Durall	officer: Chief Commercial Officer	520 LAKE COOK ROAD, SUITE 315, DEERFIELD IL 60015
Christopher Thunander	officer: Chief Accounting Officer	520 LAKE COOK ROAD, SUITE 315, DEERFIELD IL 60015
Thomas Mceachin	director	11621 RESEARCH CIRCLE, ALACHUA FL 32615
Nicholas J Valeriani	director	C/O EDWARDS LIFESCIENCES CORPORATION, ONE EDWARDS WAY, IRVINE CA 92614
Sheryl L Conley	director	C/O NEURONETICS, INC., 3222 PHOENIXVILLE PIKE, MALVERN PA 19355
Enrico Sangiorgio	officer: EVP, International	520 LAKE COOK ROAD, SUITE 315, DEERFIELD IL 60015
Stuart F. Simpson	director	520 LAKE COOK ROAD, SUITE 315, DEERFIELD IL 60015
Pawel Lewicki	director	296 WOODWARD BLVD., TULSA OK 74114
Jeffrey C Lightcap	director	152 W 57TH STREET 43RD FLOOR, NEW YORK NY 10019